Research and Articles
![](/Content/images/arrow-3-right-red.png)
Hotline
![](/Content/images/arrow-3-right-red.png)
- Capital Markets Hotline
- Companies Act Series
- Climate Change Related Legal Issues
- Competition Law Hotline
- Corpsec Hotline
- Court Corner
- Cross Examination
- Deal Destination
- Debt Funding in India Series
- Deal Talk
- Dispute Resolution Hotline
- Education Sector Hotline
- FEMA Hotline
- Financial Service Update
- Food & Beverages Hotline
- Funds Hotline
- Gaming Law Wrap
- GIFT City Express
- Green Hotline
- HR Law Hotline
- iCe Hotline
- Insolvency and Bankruptcy Hotline
- International Trade Hotlines
- Investment Funds: Monthly Digest
- IP Hotline
- IP Lab
- Legal Update
- Lit Corner
- M&A Disputes Series
- M&A Hotline
- M&A Interactive
- Media Hotline
- New Publication
- Other Hotline
- Pharma & Healthcare Update
- Press Release
- Private Client Wrap
- Private Debt Hotline
- Private Equity Corner
- Real Estate Update
- Realty Check
- Regulatory Digest
- Regulatory Hotline
- Renewable Corner
- SEZ Hotline
- Social Sector Hotline
- Tax Hotline
- Technology & Tax Series
- Technology Law Analysis
- Telecom Hotline
- The Startups Series
- White Collar and Investigations Practice
- Yes, Governance Matters.
- Japan Desk ジャパンデスク
Competition Law Hotline
March 18, 2021Competition Enforcement in India: Fresh take on Interim Measures in the Digital Sector
This article was originally published on 12th March 2021 in Kluwer Competition Law Blog.
Krithika Ramesh and Payel Chatterjee analyze the latest Competition Commission of India (“CCI”) ruling directing MakeMyTrip India Pvt. Ltd. and the Ibibo Group to re-list Treebo and Fab Hotels on their website in their recent piece published in Kluwer Competition Law Blog on 12 March, 2021.
In our piece titled “Competition Enforcement in India: Fresh take on Interim Measures in the Digital Sector”, we analyse the evidentiary standards considered by CCI and the conflation between aggregators and platforms. The CCI order has marked the emergence of a new approach between ex-ante and ex-post regulation where remedies are issued as a pre-emptive measure, pending investigation.
The complete article can be accessed here.